A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202

被引：0
|
作者：
Syma Iqbal
Cathryn Rankin
Heinz-Josef Lenz
Philip J. Gold
Syed A. Ahmad
Anthony B. El-Khoueiry
Michael J. Messino
Randall F. Holcombe
Charles D. Blanke
机构：
[1] University of Southern California,Norris Comprehensive Cancer Center
[2] Southwest Oncology Group Statistical Center,Barrett Center, Department of Surgery
[3] Swedish Cancer Institute,undefined
[4] University of Cincinnati,undefined
[5] Southeast Cancer Control Consortium,undefined
[6] Inc. CCOP,undefined
[7] Cancer Care of WNC,undefined
[8] University of California at Irvine,undefined
[9] Chao Family CCC,undefined
[10] University of British Columbia,undefined
[11] and British Columbia Cancer Agency,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 68卷
关键词：
Gemcitabine; Capecitabine; Cholangiocarcinoma; Gallbladder; Clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1595 / 1602
页数：7
相关论文
共 50 条
  • [1] A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202
    Iqbal, Syma
    Rankin, Cathryn
    Lenz, Heinz-Josef
    Gold, Philip J.
    Ahmad, Syed A.
    El-Khoueiry, Anthony B.
    Messino, Michael J.
    Holcombe, Randall F.
    Blanke, Charles D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (06) : 1595 - 1602
  • [2] SWOG S0202: A phase II trial of gemcitabine and capecitabine in patients (pts) with unresectable or metastatic gallbladder cancer or cholangiocarcinoma.
    Iqbal, S.
    McCoy, S.
    Lenz, H. J.
    Rivkin, S. E.
    Atkins, J. N.
    Blanke, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 211S - 211S
  • [3] A Phase II Study of Gemcitabine and Capecitabine in Patients With Advanced Renal Cell Cancer Southwest Oncology Group Study S0312
    Van Veldhuizen, Peter J.
    Hussey, Michael
    Lara, Primo N., Jr.
    Mack, Philip C.
    Gandour-Edwards, Regina
    Clark, Joseph I.
    Lange, Marianne K.
    Crawford, David E.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (05): : 453 - 459
  • [4] PHASE-II TRIAL OF M-AMSA IN GALLBLADDER AND CHOLANGIOCARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    BUKOWSKI, RM
    LEICHMAN, LP
    RIVKIN, SE
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (06): : 721 - 723
  • [5] A Phase II Study of Imatinib Mesylate and Capecitabine in Metastatic Breast Cancer: Southwest Oncology Group Study 0338
    Chew, Helen K.
    Barlow, William E.
    Albain, Kathy
    Lew, Danika
    Gown, Allen
    Hayes, Daniel E.
    Gralow, Julie
    Hortobagyi, Gabriel N.
    Livingston, Robert
    CLINICAL BREAST CANCER, 2008, 8 (06) : 511 - 515
  • [6] Phase II trial of gemcitabine plus irinotecan in patients with Esophageal cancer - A Southwest Oncology Group (SWOG) trial
    Williamson, SK
    McCoy, SA
    Gandara, DR
    Dakhil, SR
    Yost, KJ
    Paradelo, JC
    Atkins, JN
    Blanke, CD
    Abbruzzese, JL
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (02): : 116 - 122
  • [7] Expanded phase II trial of paclitaxel in metastatic breast cancer: A Southwest Oncology Group study
    Geyer, CE
    Green, SJ
    Moinpour, CM
    O'Sullivan, J
    Goodwin, DK
    Canfield, VA
    Meyers, FJ
    Osborne, CK
    Martino, S
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 51 (02) : 169 - 181
  • [8] Expanded phase II trial of paclitaxel in metastatic breast cancer: A Southwest Oncology Group study
    Charles E. Geyer
    Stephanie J. Green
    Carol M. Moinpour
    Janet O'Sullivan
    Donna K. Goodwin
    Vikki A. Canfield
    Frederick J. Meyers
    C. Kent Osborne
    Silvana Martino
    Breast Cancer Research and Treatment, 1998, 51 : 169 - 181
  • [9] SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma
    Anthony B. El-Khoueiry
    Cathryn J. Rankin
    Edgar Ben-Josef
    Heinz-Josef Lenz
    Philip J. Gold
    R. Darryl Hamilton
    Rangaswamy Govindarajan
    Cathy Eng
    Charles D. Blanke
    Investigational New Drugs, 2012, 30 : 1646 - 1651
  • [10] SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma
    El-Khoueiry, Anthony B.
    Rankin, Cathryn J.
    Ben-Josef, Edgar
    Lenz, Heinz-Josef
    Gold, Philip J.
    Hamilton, R. Darryl
    Govindarajan, Rangaswamy
    Eng, Cathy
    Blanke, Charles D.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1646 - 1651
12345